Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1996-02-05
1998-06-30
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514413, 540456, 540460, A61K 31395, C07D48704
Patent
active
057734283
ABSTRACT:
Compounds of formula (I): ##STR1## as single stereoisomers or mixtures thereof and their pharmaceutically acceptable salts inhibit matrix metalloproteases, such as interstitial collagenases, and are useful in the treatment of mammals having disease states alleviated by the inhibition of such matrix metalloproteases, for example arthritic diseases or bone resorption diseases, such as osteoporosis.
REFERENCES:
patent: 4511504 (1985-04-01), McCullagh et al.
patent: 4568666 (1986-02-01), McCullagh et al.
patent: 4771037 (1988-09-01), Roberts et al.
Chemical Abstracts vol. 123,1995 (13) 25 Sep. 1995, p. 24.
Cannon Paul David
Castelhano Arlindo Lucas
Chen Jian Jeffrey
Horne Stephen
Krantz Alexander
Bond Robert T.
Syntex (U.S.A.) Inc.
LandOfFree
Matrix metalloprotease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Matrix metalloprotease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Matrix metalloprotease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1859444